Melatonin and delayed sleep phase syndrome: Ambulatory polygraphic evaluation

Alessandro Oldani, Luigi Ferini-Strambi, Marco Zucconi, Bojidar Stankov, Franco Fraschini, Salvatore Smirne

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

The present study objectively evaluated the efficacy of oral 5 mg day1 melatonin in advancing the sleep-wake rhythm in patients with delayed sleep phase syndrome (DSPS). Six patients underwent ambulatory sleep monitoring for 72 h before and 48 h after 1 month of melatonin treatment. In each patient melatonin was administered on the basis of his own estimated dim light melatonin onset (DLMO) delay. Mean advances in sleep onset time of 115 min and in final awakening hour of 106 min were found after treatment, with no significant changes in sleep architecture parameters. Our study objectively confirms previous data obtained by a sleep-wake subjective diary on the efficacy of melatonin DSPS.

Original languageEnglish
Pages (from-to)132-134
Number of pages3
JournalNeuroReport
Volume6
Issue number1
Publication statusPublished - 1994

Fingerprint

Circadian Rhythm Sleep Disorders
Melatonin
Sleep
Ambulatory Monitoring
Polysomnography
Light
Therapeutics

Keywords

  • Ambulatory polygraphic monitoring
  • Delayed sleep phase syndrome
  • Melatonin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Melatonin and delayed sleep phase syndrome : Ambulatory polygraphic evaluation. / Oldani, Alessandro; Ferini-Strambi, Luigi; Zucconi, Marco; Stankov, Bojidar; Fraschini, Franco; Smirne, Salvatore.

In: NeuroReport, Vol. 6, No. 1, 1994, p. 132-134.

Research output: Contribution to journalArticle

Oldani, A, Ferini-Strambi, L, Zucconi, M, Stankov, B, Fraschini, F & Smirne, S 1994, 'Melatonin and delayed sleep phase syndrome: Ambulatory polygraphic evaluation', NeuroReport, vol. 6, no. 1, pp. 132-134.
Oldani, Alessandro ; Ferini-Strambi, Luigi ; Zucconi, Marco ; Stankov, Bojidar ; Fraschini, Franco ; Smirne, Salvatore. / Melatonin and delayed sleep phase syndrome : Ambulatory polygraphic evaluation. In: NeuroReport. 1994 ; Vol. 6, No. 1. pp. 132-134.
@article{520af7667e5e405980b8a10cd6f5e095,
title = "Melatonin and delayed sleep phase syndrome: Ambulatory polygraphic evaluation",
abstract = "The present study objectively evaluated the efficacy of oral 5 mg day1 melatonin in advancing the sleep-wake rhythm in patients with delayed sleep phase syndrome (DSPS). Six patients underwent ambulatory sleep monitoring for 72 h before and 48 h after 1 month of melatonin treatment. In each patient melatonin was administered on the basis of his own estimated dim light melatonin onset (DLMO) delay. Mean advances in sleep onset time of 115 min and in final awakening hour of 106 min were found after treatment, with no significant changes in sleep architecture parameters. Our study objectively confirms previous data obtained by a sleep-wake subjective diary on the efficacy of melatonin DSPS.",
keywords = "Ambulatory polygraphic monitoring, Delayed sleep phase syndrome, Melatonin",
author = "Alessandro Oldani and Luigi Ferini-Strambi and Marco Zucconi and Bojidar Stankov and Franco Fraschini and Salvatore Smirne",
year = "1994",
language = "English",
volume = "6",
pages = "132--134",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Melatonin and delayed sleep phase syndrome

T2 - Ambulatory polygraphic evaluation

AU - Oldani, Alessandro

AU - Ferini-Strambi, Luigi

AU - Zucconi, Marco

AU - Stankov, Bojidar

AU - Fraschini, Franco

AU - Smirne, Salvatore

PY - 1994

Y1 - 1994

N2 - The present study objectively evaluated the efficacy of oral 5 mg day1 melatonin in advancing the sleep-wake rhythm in patients with delayed sleep phase syndrome (DSPS). Six patients underwent ambulatory sleep monitoring for 72 h before and 48 h after 1 month of melatonin treatment. In each patient melatonin was administered on the basis of his own estimated dim light melatonin onset (DLMO) delay. Mean advances in sleep onset time of 115 min and in final awakening hour of 106 min were found after treatment, with no significant changes in sleep architecture parameters. Our study objectively confirms previous data obtained by a sleep-wake subjective diary on the efficacy of melatonin DSPS.

AB - The present study objectively evaluated the efficacy of oral 5 mg day1 melatonin in advancing the sleep-wake rhythm in patients with delayed sleep phase syndrome (DSPS). Six patients underwent ambulatory sleep monitoring for 72 h before and 48 h after 1 month of melatonin treatment. In each patient melatonin was administered on the basis of his own estimated dim light melatonin onset (DLMO) delay. Mean advances in sleep onset time of 115 min and in final awakening hour of 106 min were found after treatment, with no significant changes in sleep architecture parameters. Our study objectively confirms previous data obtained by a sleep-wake subjective diary on the efficacy of melatonin DSPS.

KW - Ambulatory polygraphic monitoring

KW - Delayed sleep phase syndrome

KW - Melatonin

UR - http://www.scopus.com/inward/record.url?scp=0028605306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028605306&partnerID=8YFLogxK

M3 - Article

C2 - 7703401

AN - SCOPUS:0028605306

VL - 6

SP - 132

EP - 134

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 1

ER -